| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Article |
Department of Physical Therapy (M/C 898), College of Associated Health Professions, University of Illinois at Chicago 60612-7251, USA.
The purpose of this article is to review the literature on the effects of intrathecally administered baclofen on impairment in spasticity and muscle activation patterns, on functional limitations in mobility and self-care, and on disability in daily life roles. We found plentiful evidence of improvement in spasticity, spasms, and bladder function and some reports of improved patterns of muscle activation and kinematics of single-joint movement. Improved ability to accomplish transfers, self-care, and locomotion is less consistently studied but has also been reported in about 60% to 70% of patients. Evidence of improved quality of life is primarily anecdotal but may be found in 10% to 30% of patients. We conclude that research protocols should be developed to clarify effects on control of voluntary movement, functional limitations, and quality of life.
This article has been cited by other articles:
|
|
 |
|
  G. de Lissovoy, L. S. Matza, H. Green, M. Werner, and T. Edgar Cost-effectiveness of Intrathecal Baclofen Therapy for the Treatment of Severe Spasticity Associated With Cerebral Palsy J Child Neurol, January 1, 2007; 22(1): 49 - 59. [Abstract] [PDF]
|
|
|
|
 |
|
 T. G. Hornby, J. H. Kahn, M. Wu, and B. D. Schmit Temporal facilitation of spastic stretch reflexes following human spinal cord injury J. Physiol., March 15, 2006; 571(3): 593 - 604. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E Gallichio Pharmacologic Management of Spasticity Following Stroke Physical Therapy, October 1, 2004; 84(10): 973 - 981. [Full Text] [PDF]
|
|
|
|
|
|
Y. Awaad, H. Tayem, S. Munoz, S. Ham, A. M. Michon, and R. Awaad Functional Assessment Following Intrathecal Baclofen Therapy in Children With Spastic Cerebral Palsy J Child Neurol, January 1, 2003; 18(1): 26 - 34. [Abstract] [PDF]
|
|
|
|
|
|
A. L. Albright Neurosurgical Treatment of Spasticity and Other Pediatric Movement Disorders J Child Neurol, January 1, 2003; 18(1_suppl): S67 - S78. [Abstract] [PDF]
|
|
|
|
 |
|
 N. G. Bowery, B. Bettler, W. Froestl, J. P. Gallagher, F. Marshall, M. Raiteri, T. I. Bonner, and S. J. Enna International Union of Pharmacology. XXXIII. Mammalian gamma -Aminobutyric AcidB Receptors: Structure and Function Pharmacol. Rev., June 1, 2002; 54(2): 247 - 264. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Goldstein Spasticity Management: An Overview J Child Neurol, January 1, 2001; 16(1): 16 - 23. [Abstract] [PDF]
|
|
|
|
|
|
L. E. Krach Pharmacotherapy of Spasticity: Oral Medications and Intrathecal Baclofen J Child Neurol, January 1, 2001; 16(1): 31 - 36. [Abstract] [PDF]
|
|
|
|
|
|
A. L. Albright Intrathecal Baclofen in Cerebral Palsy Movement Disorders J Child Neurol, November 1, 1996; 11(1_suppl): S29 - S35. [Abstract] [PDF]
|
|
|
|
|
|
M. J. Barry Physical Therapy Interventions for Patients With Movement Disorders due to Cerebral Palsy J Child Neurol, November 1, 1996; 11(1_suppl): S51 - S60. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
